Skip to main content
. 2019 May 28;74(8):1480–1489. doi: 10.1111/all.13842

Figure 2.

Figure 2

Patients’ flow diagram. AIT, allergen immunotherapy; N, number of patients; n, number of patients in group; IMP, Investigational Medicinal Product